TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sihuan Pharmaceutical Holdings Group ( (HK:0460) ) just unveiled an update.
Sihuan Pharmaceutical Holdings Group Ltd. announced a share repurchase of 15 million shares at an average price of HK$1.4505 per share, totaling approximately HK$21.76 million. This move is part of its strategic goal to enhance shareholder value and reflects its confidence in future growth. The company has seen significant progress in its medical aesthetics and innovative pharmaceuticals segments, with a notable revenue increase in its medical aesthetics business and the launch of several new products. These developments are expected to drive future revenue and profit growth, reinforcing Sihuan’s position in the industry.
The most recent analyst rating on (HK:0460) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Sihuan Pharmaceutical Holdings Group stock, see the HK:0460 Stock Forecast page.
More about Sihuan Pharmaceutical Holdings Group
Sihuan Pharmaceutical Holdings Group Ltd., founded in 2001 and listed on the Main Board of the Stock Exchange in 2010, is an international medical aesthetics and biopharmaceutical company. It is recognized for its innovation, independent research and development technology platform, and a comprehensive product pipeline. The company focuses on medical aesthetics and biopharmaceutical businesses, aiming to become a leading entity in these sectors in China.
Average Trading Volume: 79,395,481
Technical Sentiment Signal: Buy
Current Market Cap: HK$14.18B
For an in-depth examination of 0460 stock, go to TipRanks’ Overview page.